View in EDS

Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.

Saved in:
Bibliographic Details
Title: Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.
Authors: Smith D; University of California San Diego; La Jolla, CA, USA., Weir IR; Center for Biostatistics in AIDS Research in the Department of Biostatistics Harvard T.H. Chan School of Public Health; Boston, MA, USA., Ramirez S; University of California San Diego; La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Coelho CH; Center for Vaccine Research and Pandemic Preparedness, Department of Microbiology, and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai; New York, NY, USA., Manne-Goehler J; Brigham and Women's Hospital, Harvard Medical School; Boston, MA, USA., Aziz M; Rush University Medical Center; Chicago, IL, USA., Benson CA; University of California San Diego; La Jolla, CA, USA., Wu X; Center for Biostatistics in AIDS Research in the Department of Biostatistics Harvard T.H. Chan School of Public Health; Boston, MA, USA., Hyer R; Moderna, Inc., Cambridge, MA., Dhillon PK; DLH Corporation; Silver Spring, MD, USA., Faraji F; University of California San Diego; La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Bloom N; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Myers A; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Ramezani-Rad P; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Lopez PG; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Parikh UM; University of Pittsburgh, School of Medicine, Division of Infectious Diseases; Pittsburgh, Pennsylvania, USA., Heaps AL; University of Pittsburgh, School of Medicine, Division of Infectious Diseases; Pittsburgh, Pennsylvania, USA., Javan AC; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA., Bender Ignacio RA; University of Washington; Seattle, WA, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center; Seattle, WA, USA., Li JZ; Brigham and Women's Hospital, Harvard Medical School; Boston, MA, USA., Greninger AL; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center; Seattle, WA, USA., Daar ES; Lundquist Institute at Harbor-UCLA Medical Center; Torrance, CA, USA., Wohl DA; University of North Carolina at Chapel Hill; Chapel Hill, NC, USA., Crotty S; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA., Sieg SF; Case Western Reserve University School of Medicine; Cleveland, OH, USA.; University Hospitals of Cleveland; Cleveland, OH, USA., Chew KW; David Geffen School of Medicine at University of California, Los Angeles; Los Angeles, CA, USA.
Source: The Journal of infectious diseases [J Infect Dis] 2026 Feb 17. Date of Electronic Publication: 2026 Feb 17.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41700320
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; University of California San Diego; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Weir+IR%22">Weir IR</searchLink>; Center for Biostatistics in AIDS Research in the Department of Biostatistics Harvard T.H. Chan School of Public Health; Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ramirez+S%22">Ramirez S</searchLink>; University of California San Diego; La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Coelho+CH%22">Coelho CH</searchLink>; Center for Vaccine Research and Pandemic Preparedness, Department of Microbiology, and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai; New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Manne-Goehler+J%22">Manne-Goehler J</searchLink>; Brigham and Women's Hospital, Harvard Medical School; Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aziz+M%22">Aziz M</searchLink>; Rush University Medical Center; Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Benson+CA%22">Benson CA</searchLink>; University of California San Diego; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Center for Biostatistics in AIDS Research in the Department of Biostatistics Harvard T.H. Chan School of Public Health; Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hyer+R%22">Hyer R</searchLink>; Moderna, Inc., Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Dhillon+PK%22">Dhillon PK</searchLink>; DLH Corporation; Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Faraji+F%22">Faraji F</searchLink>; University of California San Diego; La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bloom+N%22">Bloom N</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Myers+A%22">Myers A</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ramezani-Rad+P%22">Ramezani-Rad P</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lopez+PG%22">Lopez PG</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Parikh+UM%22">Parikh UM</searchLink>; University of Pittsburgh, School of Medicine, Division of Infectious Diseases; Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Heaps+AL%22">Heaps AL</searchLink>; University of Pittsburgh, School of Medicine, Division of Infectious Diseases; Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Javan+AC%22">Javan AC</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bender+Ignacio+RA%22">Bender Ignacio RA</searchLink>; University of Washington; Seattle, WA, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Li+JZ%22">Li JZ</searchLink>; Brigham and Women's Hospital, Harvard Medical School; Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Greninger+AL%22">Greninger AL</searchLink>; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center; Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Daar+ES%22">Daar ES</searchLink>; Lundquist Institute at Harbor-UCLA Medical Center; Torrance, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wohl+DA%22">Wohl DA</searchLink>; University of North Carolina at Chapel Hill; Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Crotty+S%22">Crotty S</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology; La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sieg+SF%22">Sieg SF</searchLink>; Case Western Reserve University School of Medicine; Cleveland, OH, USA.; University Hospitals of Cleveland; Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chew+KW%22">Chew KW</searchLink>; David Geffen School of Medicine at University of California, Los Angeles; Los Angeles, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2026 Feb 17. <i>Date of Electronic Publication: </i>2026 Feb 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41700320
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiag091
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Smith D
      – PersonEntity:
          Name:
            NameFull: Weir IR
      – PersonEntity:
          Name:
            NameFull: Ramirez S
      – PersonEntity:
          Name:
            NameFull: Coelho CH
      – PersonEntity:
          Name:
            NameFull: Manne-Goehler J
      – PersonEntity:
          Name:
            NameFull: Aziz M
      – PersonEntity:
          Name:
            NameFull: Benson CA
      – PersonEntity:
          Name:
            NameFull: Wu X
      – PersonEntity:
          Name:
            NameFull: Hyer R
      – PersonEntity:
          Name:
            NameFull: Dhillon PK
      – PersonEntity:
          Name:
            NameFull: Faraji F
      – PersonEntity:
          Name:
            NameFull: Bloom N
      – PersonEntity:
          Name:
            NameFull: Myers A
      – PersonEntity:
          Name:
            NameFull: Ramezani-Rad P
      – PersonEntity:
          Name:
            NameFull: Lopez PG
      – PersonEntity:
          Name:
            NameFull: Parikh UM
      – PersonEntity:
          Name:
            NameFull: Heaps AL
      – PersonEntity:
          Name:
            NameFull: Javan AC
      – PersonEntity:
          Name:
            NameFull: Bender Ignacio RA
      – PersonEntity:
          Name:
            NameFull: Li JZ
      – PersonEntity:
          Name:
            NameFull: Greninger AL
      – PersonEntity:
          Name:
            NameFull: Daar ES
      – PersonEntity:
          Name:
            NameFull: Wohl DA
      – PersonEntity:
          Name:
            NameFull: Crotty S
      – PersonEntity:
          Name:
            NameFull: Sieg SF
      – PersonEntity:
          Name:
            NameFull: Chew KW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 02
              Text: 2026 Feb 17
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1